We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
53 hedge funds and large institutions have $461M invested in Atara Biotherapeutics in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
467% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 3
225% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 8
168% more capital invested
Capital invested by funds: $172M → $461M (+$289M)
36% more funds holding
Funds holding: 39 → 53 (+14)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
53
Holders Change
+14
Holders Change %
+35.9%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
26
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
+$59.9M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$17.9M |
| 3 |
Neuberger Berman Group
New York
|
+$10.7M |
| 4 |
Jennison Associates
New York
|
+$7.96M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$6.67M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.3M |
| 2 |
Goldman Sachs
New York
|
-$1.41M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$342K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$246K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$228K |
